Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.00
Bid: 16.00
Ask: 16.90
Change: -1.65 (-9.35%)
Spread: 0.90 (5.625%)
Open: 16.00
High: 16.40
Low: 16.00
Prev. Close: 17.65
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Annual profit rises for UP Global Sourcing, Beximco

Tue, 02nd Nov 2021 15:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

UP Global Sourcing Holdings PLC - Oldham, Greater Manchester-based consumer brands owner - For the year ended July 31, pretax profit rises 14% to GBP9.5 million from GBP8.4 million the year before, on revenue which increases 18% year-on-year to GBP136.4 million from GBP115.7 million, with consumer behaviour changing to home cooking and working fostering growth from the Small Domestic Appliances, Homewares and Laundry segments. Declares total dividend of 5.020 pence per share, up 27% from 3.955p the year before. Looking ahead, current trading is in line with expectations, despite global shipping set to remain disrupted until February next year.

----------

Beximco Pharmaceuticals Ltd - Bangladesh-based pharmaceutical company - For the year ended June 30, pretax profit rises 37% to BDT6.38 billion, around GBP54.7 million, up 37% from BDT4.65 billion, on revenue which grows 15% year-on-year to BDT29.49 billion from BDT25.61 billion, driven by double digit growth in both domestic and export sales, with the launch of 22 new products domestically. Proposes dividend of BDT3.5 per share.

----------

Triad Group PLC - Godalming, England-based software company - For the six months ended September 30, pretax profit surges to GBP67,000 from GBP1,000 a year before, with gross profit rising 54% to GBP2.3 million, driven by a focus on the group's consulting services. However, revenue drops 1.1% year-on-year to GBP8.6 million from GBP8.7 million. Proposes interim dividend of 2.0 pence per share, from none a year prior. Looking ahead, expects second half to see high utilisation levels and an increase in headcount in response to persistent demand.

----------

Gaming Realms PLC - London-based developer and licensor of mobile focused gaming content - During the third quarter of 2021, content licensing revenue rises 35% year-on-year, alongside growth in the new licensing and games pipeline. In addition, has been approved for a full iGaming Supplier Licence in Michigan.

----------

Eckoh PLC - London-based secure payment products provider - For the six months ended September 30, company performs in line with management expectations, with underlying revenue slightly higher, and operating profit rising 18%. However, total revenue was slightly lower at constant currency, due to the company's planned exit from US and UK third-party support. Looking ahead, expects performance for the full year to meet market expectations.

----------

Argo Blockchain PLC - London-based cryptocurrency miner - For the three months ended September, reports pretax profit at USD24.6 million on revenue at a record figure of USD26.0 million. During the quarter, the company mined 597 bitcoin and bitcoin-equivalent, bringing Argo's total to 1,836 as at the end of September.

----------

Shearwater Group PLC - London-based cybersecurity provider - For the six months ended September 30, expects underlying earnings before interest, tax, depreciation and amortisation to rise 19% to GBP1.3 million from GBP1.1 million a year before, due to an increasing proportion of higher margin software. Revenue, however, is set to decline 5.4% year-on-year to GBP10.6 million from GBP11.2 million.

----------

GRC International Group PLC - supplier of cyber security, risk management and compliance products - For the six months ended September 30, total billings up 26% at 6,670 from 5,583 a year before, due to continued momentum from the second half of the prior year. As a result, achieves positive earnings before interest, tax, depreciation and amortisation for the period. Look ahead, trading in October has been in line with management expectations.

----------

Watkin Jones PLC - London-based student accommodation developer and manager - For the year ended September 30, expects operating profit to be in line with expectations, on revenue forecast at GBP430 million, slightly below expectations, but up 21% from GBP354.1 million the year before.

----------

Warpaint London PLC - Buckinghamshire-based cosmetics maker - For 2021, expects sales to be at similar levels to those in 2019, which was at GBP49.3 million. For 2020, sales reached GBP40.3 million. This is due to growth from new and existing customers, despite Covi-19 disruption. Expects adjusted earnings before interest, tax, depreciation and amortisation and adjusted pretax profit to be both ahead of 2019 and current market expectations. Adjusted Ebitda in 2019 was GBP7.0 million and adjusted pretax profit was GBP5.2 million.

----------

Feedback PLC - medical imaging software company - For the year ended May 31, pretax loss widens to GBP2.1 million from GBP1.4 million the year before, on revenue which declines 36% year-on-year to GBP290,000 from GBP450,000, reflecting the planned move away from legacy products and a focus on Bleepa, and the loss is exacerbated by an expanded headcount. Also raises GBP10.7 million through a placing of 1.53 billion shares at a price of 0.7 pence each. "Funds raised will be used primarily to support accelerated revenue growth through both private and public healthcare revenue opportunities within both the NHS and other healthcare systems in the UK and overseas," it says. Will also look to raise an additional GBP500,000 via an open offer to eligible shareholders.

----------

Oncimmune Holdings PLC - Nottingham, England-based diagnostics company - For the year ended May 31, pretax loss narrows to GBP5.7 million from GBP9.8 million the year before, on revenue which soared to GBP3.7 million from GBP509,000, driven by a rise in the number of contracts awarded, leading to the growth of the ImmunoINSIGHTS' business. Looking ahead, due to growth from ImmunoINSIGHTS, company expects profitability and cash generation to improve. Notes "quieter than expected summer months" in which fewer new ImmunoINSIGHTS contracts were signed than originally expected, but says there has been healthy resumption of activity.

----------

Rutherford Health PLC - Hereford, England-based cancer care centre provider - For the six months ended August 31, pretax loss widens to GBP19.9 million from GBP15.7 million a year prior due to higher expenses, particularly employee costs and preparation for the opening of the first Rutherford Diagnostics Centre in Somerset. Revenue however rises 36% year-on-year to GBP4.9 million from GBP3.6 million, due to the group's expansion within Diagnostics, and a rise in SACT treatments across all centres.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
4 Mar 2020 12:57

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Oncimmune EarlyCDT Lung Test Launched In US By Commercial Partner

Read more
12 Feb 2020 09:10

Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses

Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses

Read more
28 Jan 2020 13:52

Oncimmune Reports Study Results For Cancer Test Product

Oncimmune Reports Study Results For Cancer Test Product

Read more
22 Nov 2019 16:05

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Nov 2019 13:33

Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test

Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test

Read more
31 Oct 2019 11:38

Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress

Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress

Read more
25 Sep 2019 11:32

CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility

CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility

Read more
23 Sep 2019 16:08

Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks

Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks

Read more
20 Sep 2019 15:47

Oncimmune funded into 2021 with new EUR 8.5m facility

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has secured a credit facility of €8.5m (£7.5m) with IPF Management, it announced on Friday.

Read more
20 Sep 2019 14:04

Oncimmune Secures EUR8.5 Billion Debt For Products Commercialisation

(Alliance News) - Oncimmune Holdings PLC on Friday said it has secured a credit facility of EUR8.5 million with IPF Management SA.The immunodiagnostics company said it will immediately draw

Read more
9 Sep 2019 12:07

Oncimmune "Thrilled" With EarlyCDT Lung Cancer Test Trial Result

(Alliance News) - Oncimmune Holdings PLC on Monday announced positive results from a trial of its EarlyCDT Lung test to detect early stage lung cancer.Shares in Oncimmune were up 5.5% at in

Read more
15 Jul 2019 12:55

Oncimmune Further Expands EarlyCDT Lung Sales In Spain Through Vithas

(Alliance News) - Oncimmune Holdings PLC on Monday said Sabartech SL, its existing distributor in Spain and Portugal, has agreed with Vithas Group to sell EarlyCDT Lung as a screening test for of

Read more
28 Jun 2019 11:03

Oncimmune sells US operations to and partners with Biodesix

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has entered into an exclusive partnership agreement, it announced on Friday, which it said could "unlock the full potential" of its 'EarlyCDT Lung' product in the United States.

Read more
26 Jun 2019 10:58

Oncimmune confident of 'material profitable revenues'

(Sharecast News) - Immunodiagnostics firm Oncimmune told investors on Wednesday it was confident it could generate "material profitable revenues" on the back of several business developments.

Read more
4 Jun 2019 09:56

Oncimmune Holdings Reports Positive Lung Cancer Study Results

LONDON (Alliance News) - Oncimmune Holdings PLC on Tuesday reported positive top line results from its early cancer detection test in patients with lung cancer.Oncimmune Holdings shares at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.